Literature DB >> 24804898

Enkephalin knockout male mice are resistant to chronic mild stress.

I Melo1, E Drews, A Zimmer, A Bilkei-Gorzo.   

Abstract

Enhanced stress reactivity or sensitivity to chronic stress increases the susceptibility to mood pathologies such as major depression. The opioid peptide enkephalin is an important modulator of the stress response. Previous studies using preproenkephalin knockout (PENK KO) mice showed that these animals exhibit abnormal stress reactivity and show increased anxiety behavior in acute stress situations. However, the consequence of enkephalin deficiency in the reactivity to chronic stress conditions is not known. In this study, we therefore submitted wild-type (WT) and PENK KO male mice to chronic stress conditions, using the chronic mild stress (CMS) protocol. Subsequently, we studied the CMS effects on the behavioral and hormonal level and also performed gene expression analyses. In WT animals, CMS increased the expression of the enkephalin gene in the paraventricular nucleus (PVN) of the hypothalamus and elevated the corticosterone levels. In addition, WT mice exhibited enhanced anxiety in the zero-maze test and depression-related behaviors in the sucrose preference and forced swim tests. Surprisingly, in PENK KO mice, we did not detect anxiety and depression-related behavioral changes after the CMS procedure, and even measured a decreased hormonal stress response. These results indicate that PENK KO mice are resistant to the CMS effects, suggesting that enkephalin enhances the reactivity to chronic stress.
© 2014 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  Anxiety; depression; enkephalin; gene expression; paraventricular nucleus

Mesh:

Substances:

Year:  2014        PMID: 24804898     DOI: 10.1111/gbb.12139

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  8 in total

1.  Reported Benefits of Low-Dose Naltrexone Appear to Be Independent of the Endogenous Opioid System Involving Proopiomelanocortin Neurons and β-Endorphin.

Authors:  Marissa J Metz; Caitlin M Daimon; Shane T Hentges
Journal:  eNeuro       Date:  2021-06-16

2.  Faecal corticosterone metabolite assessment in socially housed male and female Wistar rats.

Authors:  Carlo Cinque; Manuela Zinni; Anna Rita Zuena; Chiara Giuli; Sebastiano G Alemà; Assia Catalani; Paola Casolini; Roberto Cozzolino
Journal:  Endocr Connect       Date:  2018-01-04       Impact factor: 3.335

Review 3.  Enkephalins: Endogenous Analgesics with an Emerging Role in Stress Resilience.

Authors:  Mathilde S Henry; Louis Gendron; Marie-Eve Tremblay; Guy Drolet
Journal:  Neural Plast       Date:  2017-07-11       Impact factor: 3.599

Review 4.  Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response.

Authors:  Burcu Balkan; Sakire Pogun
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  Cell type-specific transcriptional programs in mouse prefrontal cortex during adolescence and addiction.

Authors:  Aritra Bhattacherjee; Mohamed Nadhir Djekidel; Renchao Chen; Wenqiang Chen; Luis M Tuesta; Yi Zhang
Journal:  Nat Commun       Date:  2019-09-13       Impact factor: 14.919

Review 6.  Novel Pharmacological Approaches to the Treatment of Depression.

Authors:  Elias Elias; Ariel Y Zhang; Melissa T Manners
Journal:  Life (Basel)       Date:  2022-01-28

7.  Involvement of the CXCL12 System in the Stimulatory Effects of Prenatal Exposure to High-Fat Diet on Hypothalamic Orexigenic Peptides and Behavior in Offspring.

Authors:  Kinning Poon; Jessica R Barson; Huanzhi Shi; Guo Qing Chang; Sarah F Leibowitz
Journal:  Front Behav Neurosci       Date:  2017-05-17       Impact factor: 3.558

8.  Analysis of Differentially Expressed Genes in the Dentate Gyrus and Anterior Cingulate Cortex in a Mouse Model of Depression.

Authors:  Yicong Wei; Keming Qi; Yi Yu; Wei Lu; Wei Xu; Chengzi Yang; Yu Lin
Journal:  Biomed Res Int       Date:  2021-02-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.